This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Hoffmann-La Roche Inc., Cyclenium Pharma Inc.. Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2024
Title: Dwight MacDonald - Innovator in Peptide Macrocycles
Introduction
Dwight MacDonald is a prolific inventor based in Pointe-Claire, Canada, known for his contributions to the field of peptide macrocycles. With a remarkable portfolio of five patents, MacDonald's work focuses on addressing critical healthcare challenges, particularly against antibiotic-resistant bacteria.
Latest Patents
Among his recent innovations, MacDonald has developed compounds of formula (I) that serve as peptide macrocycles targeting Acinetobacter baumannii. These compounds present promising solutions in the fight against this persistent pathogen, highlighting MacDonald's dedication to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, MacDonald has collaborated with notable companies, including Hoffmann-La Roche Inc. and Cyclenium Pharma Inc. His experiences in these prestigious organizations have refined his skills and expertise in the pharmaceutical industry, allowing him to make significant contributions to researching and developing innovative therapeutic solutions.
Collaborations
MacDonald has also worked alongside esteemed colleagues Helmut Thomas and Amal Wahhab. Their collaborative efforts have enriched the research environment and fostered innovations that push the boundaries of what is currently possible in peptide technology.
Conclusion
With a strong foundation in the development of novel compounds and a commitment to addressing pressing health issues, Dwight MacDonald continues to be a vital figure in the field of innovation. His work not only exemplifies ingenuity but also contributes significantly to the advancement of therapeutic options available in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
